Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Study of fluorescein glucuronide

II. A comparative ocular kinetic study of fluorescein and fluorescein glucuronide

  • 36 Accesses

  • 24 Citations


Comparative studies of fluorescein and fluorescein glucuronide were carried out. Binding to human serum protein was studied using an Amicon MPS-3 ultrafiltration unit; it averaged 63% for fluorescein glucuronide and 85% for fluorescein. Intracameral penetration of both compounds was studied in the human eye, and the concentration changes of both compounds in the plasma ultrafiltrate and in the anterior chamber were analyzed, based on Davson's equation. The coefficient of entry into the anterior chamber (k i ) was 0.018 ± 0.007 h−1 (mean ± SD,n = 10) for fluorescein glucuronide and 0.054 ± 0.033 h−1 for fluorescein, and the former was significantly lower than the latter (P < 0.005). The rate of loss from the vitreous (k v ) was studied by injecting each compund into the vitreous of the pigmented rabbit and following the fluorescein intensity changes in it. It was 0.042 ± 0.008 h−1 (mean ± SD,n = 8) for fluorescein glucuronide and 0.17 ± 0.01 h−1 for fluorescein, and the former was significantly smaller than the latter (P < 0.001). Intraperitoneal injection of probenecid significantly decreased thek v of fluorescein but had little effection that of fluorescein glucuronide. It was suggested that fluorescein glucuronide is lost from the vitreous mainly by a passive mechanism.

This is a preview of subscription content, log in to check access.


  1. Araie M, Sawa M, Nagataki S, Mishima S (1980) Aqueous humor dynamics in man as studied by oral fluorescein. Jpn J Ophthalmol 24:346–362

  2. Blair NP, Zeimer RC, Rusin MM, Cunha-Vaz JG (1983) Outward transport of fluorescein from the vitreous in normal human subjects. Arch Ophthalmol 101:1117–1121

  3. Brubaker RF, Penninston JT, Grotte DA, Nagataki S (1982) Measurement of fluorescein binding in human plasma using fluorescence polarization. Arch Ophthalmol 100: 625–630

  4. Chen SC, Nakamura H, Tamura Z (1980a) Studies on the metabolites of fluorescein in rabbit and human urine. Chem Pharm Bull 28:1403–1407

  5. Chen SC, Nakamura H, Tamura Z (1980b) Determination of fluorescein and fluorescein monoglucuronide excreted in the urine. Chem Pharm Bull 28:2812–2816

  6. Cunha-Vaz J, Maurice D (1969) Fluorescein dynamics in the eye. Doc Ophthalmol 26:61–72

  7. Davson H (1969) The intraocular fluids. In: Davson H (ed) The eye, vol 1. Academic Press, New York London, pp 67–188

  8. Goldmann H (1950) Über Fluorescein in der menschlichen Vorderkammer. Kammerwasser-Minutenvolumen des Menschen. Ophthalmologica 119–120:65–95

  9. Grimes PA, Stone RA, Laties AM, Li W (1982) Carboxyfluorescein. A probe of the blood-ocular barriers with lower membrane permeability than fluorescein. Arch Ophthalmol 100: 635–639

  10. Grotte D, Mattox V, Brubaker RF (1985) Fluorescent, physiological and pharmacokinetic properties of fluorescein glucuronide. Exp Eye Res 40:23–33

  11. Jampol LM, Cunha-Vaz J (1984) Diagnostic agents in ophthalmology: fluorescein and other dyes. In: Sears ML (ed) The pharmacology of the eye. Springer-Verlag, Berlin Heidelberg New York Tokyo, pp 699–714

  12. Kaiser RJ, Maurice DM (1964) The diffusion of fluorescein in the lens. Exp Eye Res 3:156–165

  13. Kinsey VE, Palm E (1955) Posterior and anterior aqueous humor formation. Arch Ophthalmol 53:330–344

  14. Krogsaa B, Lund-Andersen H, Mehlsen J, Sestoft L, Larsen J (1981) Blood-retinal barrier permeability in diabetic patients. Acta Ophthalmol 59:689–694

  15. Li W, Rockey JH (1982) Fluorescein binding to normal human serum protein demonstrated by equilibrium dialysis. Arch Ophthalmol 100:484–487

  16. Lund-Andersen H, Krogsaa B (1982) Fluorescein in human plasma in vitro. Acta Ophthalmol 60:701–708

  17. Lund-Andersen H, Krogsaa B, Jensen PK (1982) Fluorescein in human plasma in vivo. Acta Ophthalmol 60:709–716

  18. Maurice DM (1980) Drug exchange between the blood and vitreous. In: Cunha-Vaz JG (ed) The blood-retinal barriers. Plenum Press, New York, pp 165–178

  19. Maurice DM, Mishima S (1984) Ocular pharmacokinetics. In: Sears ML (ed) The pharmacology of the eye. Springer-Verlag, Berlin Heidelberg New York Tokyo, pp 19–116

  20. McLaren JW, Brubaker RF (1984) Fluorescein and fluorescein glucuronide in ocular fluorophotometry. Invest Ophthalmol Vis Sci 25 [ARVO Abstracts, p 106]

  21. Nagataki S (1975) Aqueous humor dynamics of human eyes as studied using fluorescein. Jpn J Ophthalmol 19:235–249

  22. Nagataki S, Matsunaga I (1984) Binding of fluorescein monoglucuronide to human serum albumin. Invest Ophthalmol Vis Sci 25 [ARVO Abstracts, p 11]

  23. Palestine AG, Brubaker RF (1981) Pharmacokinetics of fluorescein in the vitreous. Invest Ophthalmol Vis Sci 21:542–549

  24. Rockey JH, Li W, Eccleston JF (1983) Binding of fluorescein and carboxyfluorescein by human serum proteins: significance of kinetic and equilibrium parameters of association in ocular fluorometric studies. Exp Eye Res 37:455–466

  25. Salminen L, Fischer W, Jantti V, Weigelin E (1981) Rate of loss of intravitreally injected fluorescein and EDTA in the rabbit eye. Ophthalmic Res 13:60–64

  26. Webb JM, Fonda M, Brouwer EA (1962) Metabolism and excretion patterns of fluorescein and certain halogenated fluorescein dyes in rats. J Pharm Exp Therap 137:141–147

  27. Zeimer RC, Blair NP, Cunha-Vaz J (1983) Pharmacokinetic interpretation of vitreous fluorophotometry. Invest Ophthalmol Vis Sci 24:1347–1381

  28. Zweig K, Cunha-Vaz J, Peyman G, Stein M, Raichand M (1981) Effect of argon laser photocoagulation of fluorescein transport across the blood-retinal barrier. Exp Eye Res 32:323–329

Download references

Author information

Correspondence to M. Araie.

Additional information

Read in part at the International Symposium on Ocular Fluorophotometry, Sarasota, April 28, 1984

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Seto, C., Araie, M. & Takase, M. Study of fluorescein glucuronide. Graefe's Arch Clin Exp Ophthalmol 224, 113–117 (1986).

Download citation


  • Public Health
  • Fluorescein
  • Intensity Change
  • Human Serum
  • Intraperitoneal Injection